Literature DB >> 10974693

Review of US medical school finances, 1998-1999.

J Y Krakower1, T Y Coble, D J Williams, R F Jones.   

Abstract

Based on data from the Annual Medical School Questionnaire of the Liaison Committee on Medical Education, to which 100% of the 125 accredited allopathic US medical schools responded, we found that revenue supporting programs and activities of the 125 accredited medical schools in the United States totaled $39,761 million in 1998-1999. Three sources accounted for 79.3% of total revenues: practice plans ($13,724 million; 34.5%), grants and contracts ($11, 982 million; 30.1%), and hospital support ($5814 million; 14.6%). In the aggregate, total revenues increased by 7.4% between 1997-1998 and 1998-1999, a consequence at least in part due to a 2.9% increase in the number of full-time faculty. The largest increase in dollar amount came from grants and contracts ($1101 million; 10.2% increase). Revenue increases were not evenly distributed across the schools. Increases of 10% or more in key revenue sources-practice plans and hospital support-were reported by approximately one fourth of all schools. Another one fourth reported decreases in these same sources. JAMA. 2000;284:1127-1129

Entities:  

Mesh:

Year:  2000        PMID: 10974693     DOI: 10.1001/jama.284.9.1127

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  2 in total

1.  Do Family Responsibilities and a Clinical Versus Research Faculty Position Affect Satisfaction with Career and Work-Life Balance for Medical School Faculty?

Authors:  Laurel Beckett; Jasmine Nettiksimmons; Lydia Pleotis Howell; Amparo C Villablanca
Journal:  J Womens Health (Larchmt)       Date:  2015-06       Impact factor: 2.681

2.  Stratification of Health Professional Education and Its Funding Disparities: Evidence From China During the Period of 1998-2017.

Authors:  Wenjuan Gao; Wenzhuo Li; Yue Zang; Yuxin Zhong; Hongbin Wu
Journal:  Front Public Health       Date:  2022-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.